Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Xtacy Therapeutics ( (TSE:LOAN) ) is now available.
Pegasus Mercantile Inc. has signed a CDN$2,000,000 convertible secured promissory note with Solo Beverage Company Inc. The agreement includes a two-year term at a 12% annual interest rate, with Pegasus having the option to convert the note at any time during the term. Additionally, Pegasus has secured stock warrants in Solo equivalent to 20% of the note’s value. This strategic investment aims to expand Solo’s reach, particularly through its newly acquired brand, The Classics, into markets in the USA, Europe, and South America.
More about Xtacy Therapeutics
Pegasus Mercantile Inc. is a prospect generator that provides financial, operational, and management assistance to high growth companies in the fast-growing consumer products market. The company focuses on global wellness and healthcare-related target companies.
YTD Price Performance: -20.0%
Average Trading Volume: 41,042
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.22M
See more insights into LOAN stock on TipRanks’ Stock Analysis page.
